OBM Neurobiology is an international peer-reviewed Open Access journal published quarterly online by LIDSEN Publishing Inc. By design, the scope of OBM Neurobiology is broad, so as to reflect the multidisciplinary nature of the field of Neurobiology that interfaces biology with the fundamental and clinical neurosciences. As such, OBM Neurobiology embraces rigorous multidisciplinary investigations into the form and function of neurons and glia that make up the nervous system, either individually or in ensemble, in health or disease. OBM Neurobiology welcomes original contributions that employ a combination of molecular, cellular, systems and behavioral approaches to report novel neuroanatomical, neuropharmacological, neurophysiological and neurobehavioral findings related to the following aspects of the nervous system: Signal Transduction and Neurotransmission; Neural Circuits and Systems Neurobiology; Nervous System Development and Aging; Neurobiology of Nervous System Diseases (e.g., Developmental Brain Disorders; Neurodegenerative Disorders).

OBM Neurobiology  publishes a variety of article types (Original Research, Review, Communication, Opinion, Comment, Conference Report, Technical Note, Book Review, etc.). Although the OBM Neurobiology Editorial Board encourages authors to be succinct, there is no restriction on the length of the papers. Authors should present their results in as much detail as possible, as reviewers are encouraged to emphasize scientific rigor and reproducibility.

Publication Speed (median values for papers published in 2023): Submission to First Decision: 7.5 weeks; Submission to Acceptance: 15.9 weeks; Acceptance to Publication: 7 days (1-2 days of FREE language polishing included)

Current Issue: 2024  Archive: 2023 2022 2021 2020 2019 2018 2017

Special Issue

Gluten-Related Neurological Disorders

Submission Deadline: June 30, 2020 (Open) Submit Now

Guest Editor

Luis Rodrigo, Ph.D

Professor, Gastroenterology Service, Hospital Universitario Central de Asturias, University of Oviedo, Asturias, Spain

Website | E-Mail

Research Interests: Colon Cancer; Hepatocellular Carcinoma; Hepatocellular carcinoma; Liver Cirrhosis; Celiac Disease; Autoimmune related diseases; Neurologic Diseases Gluten-related; Rheumatologic diseases; Sepsis; Infectious Diseases

About This Topic

Celiac disease (CD) has been associated several decades ago, with several neurologic disorders including the cerebellar ataxia, the multiple peripheral neuropathy, some forms of epilepsy and of depression. Recent studies have shown that a great variety of nurologic syndromes and diseases may be associated not only with CD, but also with a minor form of presentation of gluten intolerance known as “Non-celiac gluten sensitivity” (NCGS) that shows a similar clinical manifestations, but the serologic, genetic and histologic markers characteristic of CD, may be absent. The list of neurologic diseases related to CD and also to NCGS has been grown in the last years including the migraines, chorea, mononeuritis, Guillain-Barre-like síndrome, Tourette´s syndrome and others…

It remains unclear if the pathogenesis of the great part of these neurologic diseases must be related directly to the gluten toxicity or through some immonologic mechanisms. But in a great part of clinical neurologic cases, without an efficient therapy, a trial of a gluten-free diet (GFD) during at least one year merits to be proved.

In this special edition, we invite submissions that show case new, inventive and original approaches to longstanding issues in CD and NCGS assessment, treatment and research. Original research reports, review articles, communications, and perspectives are welcome in all areas pertinent to this topic. All accepted papers will be published free of charge.

Manuscript Submission Information

Manuscripts should be submitted through the LIDSEN Submission System. Detailed information on manuscript preparation and submission is available in the Instructions for Authors. All submitted articles will be thoroughly refereed through a single-blind peer-review process and will be processed following the Editorial Process and Quality Control policy. Upon acceptance, the article will be immediately published in a regular issue of the journal and will be listed together on the special issue website, with a label that the article belongs to the Special Issue. LIDSEN distributes articles under the Creative Commons Attribution (CC BY 4.0) License in an open-access model. The authors own the copyright to the article, and the article can be free to access, distribute, and reuse provided that the original work is correctly cited.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). Research articles and review articles are highly invited. Authors are encouraged to send the tentative title and abstract of the planned paper to the Editorial Office (neurobiology@lidsen.com) for record. If you have any questions, please do not hesitate to contact the Editorial Office.

Welcome your submission!


Open Access Review

Migraine as a Common Extra-Intestinal Presentation of Celiac Disease

Received: 18 August 2020;  Published: 09 February 2021;  doi: 10.21926/obm.neurobiol.2101087


Celiac disease (CD) is a common gluten-related enteropathy that presents several extra-intestinal manifestations. Migraine is globally recognized as one of the most diffuse primary headaches. The present paper aims to review the current evidence on the possible association between CD and migraine. Both adults and children having CD exhibit [...]
Open Access Review

Celiac Disease and Associated Extraintestinal Manifestations, with Special Reference to Neurological Disorders

Received: 13 July 2020;  Published: 30 October 2020;  doi: 10.21926/obm.neurobiol.2004074


Celiac disease (CD), also known as gluten-sensitive enteropathy and nontropical sprue, is one of the most important entities of the wide spectrum of gluten-related disorders (GRDs). It is well known that neurological manifestations can be present either at the onset of CD, or appear during the development of the pathology, and the neurologic [...]
Open Access Case Report

A Case of Coincidental Association of Amyotrophic Lateral Sclerosis in a Patient with Celiac Disease Consuming a Gluten-Free Diet

Received: 30 June 2020;  Published: 12 October 2020;  doi: 10.21926/obm.neurobiol.2004073


We report, for the first time, the case of amyotrophic lateral sclerosis (ALS) onset in a 54-year-old woman not following a strict gluten-free diet (GFD) for six years after the diagnosis of celiac disease (CD). The patient did not display any sign of gluten toxicity, malabsorption, or CD-related comorbidity. Previous cases reported in medical [...]
Open Access Case Report

Behavioral Disorders and Celiac Disease: Coincidence or Casualty?

Received: 10 May 2020;  Published: 24 July 2020;  doi: 10.21926/obm.neurobiol.2003067


This paper presents the case of a child diagnosed with both celiac disease and Asperger’s syndrome. The literature does not report this association to date, and the authors believe it to be a coincidence rather than a casualty.
Open Access Review

Neurological Manifestations of the Celiac Disease in Children

Received: 07 May 2020;  Published: 17 July 2020;  doi: 10.21926/obm.neurobiol.2003066


Gluten-related disorders (GRDs) represent a spectrum of diverse clinical manifestations triggered by the ingestion of gluten in genetically susceptible individuals. The most common and widely recognized diseases within this spectrum are celiac disease and non-celiac gluten sensitivity. The clinical manifestations are intestinal, but extraintes [...]
Open Access Review

Neurological Manifestations of Celiac Disease and Non-Celiac Gluten Sensitivity and the Effect of a Gluten Free Diet

Received: 17 May 2020;  Published: 10 July 2020;  doi: 10.21926/obm.neurobiol.2003065


Celiac disease (CeD) is an immune-mediated enteropathy triggered by gluten ingestion and affects nearly 1% of the population worldwide. CeD has typically been associated with gastrointestinal symptoms such as diarrhea and abdominal pain; however, its extra-intestinal manifestations are becoming widely recognized. In particular, CeD patients [...]